Inflammatory Bowel Disease: Crohn's vs Ulcerative Colitis, Explained

If you're living in Pattaya or flying in for care, few things are as disruptive as a gut that won't settle — months of diarrhoea, cramping, fatigue, and the worry that something is genuinely wrong rather than "just a bad stomach." Inflammatory bowel disease is one of the conditions behind that picture, and it's frequently confused with milder problems or self-treated for far too long. This guide explains what IBD really is, how its two main forms — Crohn's disease and ulcerative colitis — differ, how doctors treat it, and where cell-based research honestly stands. It's general education, not a diagnosis. If you'd like the wider context first, start with our guide to what an autoimmune disease is.

What is inflammatory bowel disease?

Inflammatory bowel disease (IBD) is chronic, immune-mediated inflammation of the digestive tract — the immune system drives ongoing inflammation in the gut rather than fighting a passing infection ¹⁵. The two main forms are Crohn's disease and ulcerative colitis. Both are long-term conditions that tend to run a relapsing-remitting course, but they differ in where they strike and how deep the inflammation goes ²⁵.

The exact cause isn't fully understood. The current picture is that, in genetically susceptible people, the immune system over-reacts to the normal bacteria in the gut, producing inflammation that damages the bowel wall ¹. It is not something you "catch", and it is not caused by anything you did wrong — though smoking, diet, and the gut environment all feed into risk.

How are Crohn's and ulcerative colitis different?

This is the distinction that matters most, because it shapes treatment. The two diseases differ along three lines — location, pattern, and depth:

• Crohn's disease can affect anywhere along the digestive tract, from the mouth to the anus, though it most often involves the end of the small intestine and the start of the colon. The inflammation comes in patchy "skip" areas — diseased stretches separated by healthy ones — and it can reach through the full thickness of the bowel wall ¹⁵.
• Ulcerative colitis is more confined. It affects only the colon and rectum, the inflammation is continuous rather than patchy, and it involves only the inner lining of the bowel (the mucosa) ²⁵.

In practice some cases sit in between and take time to classify, but this map of location, pattern, and depth is the framework gastroenterologists work from.

Is IBD the same as IBS?

No — and this is one of the most common and important mix-ups. The names sound alike, but they are entirely different problems. IBD (inflammatory bowel disease) causes visible, measurable inflammation and real tissue damage that a doctor can see on a colonoscopy and detect in blood and stool tests ¹⁵. IBS (irritable bowel syndrome) is a functional disorder — the gut is irritable and symptomatic, but there is no inflammation and no damage to the bowel ⁵. IBS is uncomfortable but does not scar the gut or raise cancer risk; IBD is a more serious condition that needs ongoing medical management. Telling them apart is exactly why persistent gut symptoms deserve proper investigation rather than guesswork.

What are the symptoms?

Both forms of IBD share a core cluster of symptoms, which tend to come and go with the disease activity ¹²:

• Persistent diarrhoea — often the most disruptive symptom, lasting weeks rather than days.
• Abdominal pain and cramping, frequently in the lower abdomen.
• Rectal bleeding or bloody stools — especially common in ulcerative colitis ².
• Fatigue — a heavy, persistent tiredness that's easy to underestimate.
• Unintended weight loss, and in younger patients, poor growth.

Because the inflammation is systemic, IBD can also reach beyond the gut — affecting the joints, eyes, skin, and liver in some people ⁵. The relapsing-remitting rhythm is characteristic: stretches of active disease (flares) alternate with quieter periods of remission. IBD most often begins between the ages of about 15 and 30, with a smaller second peak appearing after around 60 ⁵.

What complications can IBD cause?

The complications differ by disease, which again traces back to depth and location. Because Crohn's inflammation goes through the full bowel wall, it can lead to strictures — narrowed segments that can block the passage of food and cause obstruction — and to fistulas, abnormal tunnel-like tracts between the bowel and another surface, including the troublesome perianal fistulas around the anus ¹⁵.

Ulcerative colitis carries a different long-term concern: long-standing, extensive disease raises the risk of colorectal cancer, which is why guidelines recommend beginning surveillance colonoscopy roughly 8 to 10 years after diagnosis to catch early changes ⁵. This is one reason why "feeling fine" is not the same as being safe — monitoring continues even in remission.

How is IBD treated?

There is well-established, proven care for IBD, and it should always come first. Treatment aims to calm active inflammation, keep the disease in remission, and protect the bowel over the long term ³. The main tools are ²³:

• Aminosalicylates (5-ASA) — anti-inflammatory drugs used mainly for mild-to-moderate ulcerative colitis.
• Corticosteroids — to bring a flare under control quickly; they are not used for long-term maintenance because of side effects.
• Immunomodulators — drugs such as azathioprine that dampen the over-active immune response over time.
• Biologics — targeted therapies, including anti-TNF agents, that block specific drivers of inflammation; a major advance for moderate-to-severe disease.
• Surgery — sometimes necessary. Importantly, removing the colon (colectomy) can cure ulcerative colitis, because the disease lives only in the colon — but surgery is not curative for Crohn's, which can recur elsewhere in the gut ²³.

Alongside medication, diet, smoking cessation (which particularly helps Crohn's), and steady specialist follow-up are part of living well with IBD.

What we see at the clinic

People sometimes arrive in Pattaya hoping that a stem-cell infusion will be a shortcut around the gastroenterology that IBD really needs — and we are straight with them: it isn't. We do not replace specialist bowel care, and we don't offer stem cells as a treatment for IBD. The history here is a useful caution. A cell therapy called darvadstrocel (Alofisel) — allogeneic mesenchymal stem cells from donor fat tissue — was approved in the EU in 2018 for treatment-refractory complex perianal fistulas in Crohn's, a single narrow indication. But its confirmatory trial failed to confirm the benefit, and the EMA's marketing authorisation was withdrawn in December 2024 ⁶. Beyond that, systemic MSC therapy for IBD generally remains investigational and unproven ⁷. The honest message is the same one we give for any autoimmune condition: proven biologics and a gastroenterologist first, and a healthy scepticism toward any clinic marketing a stem-cell "cure" for IBD. If you're weighing cell-based options in general, our guide to whether regenerative medicine is right for you is a more honest starting point.

Common questions

Is IBD curable? There is no medical cure for Crohn's disease — treatment controls it but the disease can persist or recur. Ulcerative colitis is the exception in one sense: because it's confined to the colon, surgically removing the colon can cure it, though that's a major decision reserved for specific situations ²³.

How is IBD diagnosed? There's no single test. Diagnosis combines symptoms, blood and stool tests for inflammation, imaging, and — crucially — colonoscopy with biopsies to see and sample the inflamed tissue directly ⁵. This is also how IBD is distinguished from IBS.

Can diet alone treat it? Diet matters for symptoms and nutrition, and some dietary approaches help, but diet alone does not control the underlying inflammation of IBD — that needs medication and specialist care ³. Be wary of any diet sold as a cure.

Should I be worried about cancer? For most people with IBD the day-to-day risk is from flares, not cancer. But long-standing, extensive ulcerative colitis does raise colorectal-cancer risk, which is exactly why surveillance colonoscopy is recommended starting around 8 to 10 years after diagnosis ⁵.

Is IBD common in Asia? Historically less so than in the West, but incidence is rising across industrialising parts of Asia — a shift researchers link to changes in diet, environment, and the gut microbiome. For expats, that's a reason to take persistent gut symptoms seriously rather than assume it "can't be IBD here."

Key takeaway

Inflammatory bowel disease is chronic, immune-driven inflammation of the gut, and its two forms differ in a way that shapes everything: Crohn's can strike anywhere from mouth to anus, in patches, through the full bowel wall, while ulcerative colitis stays continuous in the lining of the colon and rectum ¹². It is not the same as IBS, and it responds to proven, well-established care — 5-ASA drugs, steroids for flares, immunomodulators, biologics, and sometimes surgery ²³. Cell-based therapy is a research frontier, not a cure: the one approved product for Crohn's fistulas had its authorisation withdrawn in 2024 ⁶, and systemic stem-cell therapy for IBD remains unproven ⁷. See a gastroenterologist, treat the inflammation that's measurable, and be sceptical of anyone promising a shortcut.